PAB whats so shocking this is why its trading at $7m with $5m...

PAB whats so shocking this is why its trading at $7m with $5m cash in the bank so an EV of $2m
If trials were on track and everything was rosey they would be capped at $30m+
You get what you pay for and right now with PAB you are getting an almost cash backed Bio thats trying to come out of a mess

Trials have been on hold with no updates and this just explains why but at least new CEO is trying to rectify the mistakes of the past, if PAT SM6 was no good as suggested cant see why the new credible CEO would still be keen to progress forward with it and alos looks like hes looking at other potential opportunities

“Given the therapeutic responses observed in patients treated with PAT-SM6 and PAT-SC1,
in the clinic, Patrys remains committed to realising the potential of IgMs.
The Company will be reviewing its strategy moving forward in regard to IgMs, including the potential for process improvements based on lessons learned from this latest manufacturing set back.
The Company also continues to evaluate strategic collaborations and other complementary assets with a view to maximising value creation and investor return.”